US Bancorp’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.74K | Sell |
403
-212
| -34% | -$1.97K | ﹤0.01% | 3713 |
|
|
2025
Q1 | $4.51K | Buy |
615
+298
| +94% | +$2.18K | ﹤0.01% | 3678 |
|
|
2024
Q4 | $2.71K | Sell |
317
-578
| -65% | -$4.94K | ﹤0.01% | 3797 |
|
|
2024
Q3 | $7.79K | Sell |
895
-1,460
| -62% | -$12.7K | ﹤0.01% | 3438 |
|
|
2024
Q2 | $16.1K | Buy |
+2,355
| New | +$16.1K | ﹤0.01% | 3140 |
|
|
2022
Q4 | – | Sell |
-3,011
| Closed | -$12K | – | 4213 |
|
|
2022
Q3 | $12K | Buy |
+3,011
| New | +$12K | ﹤0.01% | 3298 |
|
|
2022
Q1 | – | Sell |
-707
| Closed | -$5K | – | 4122 |
|
|
2021
Q4 | $5K | Sell |
707
-81,793
| -99% | -$578K | ﹤0.01% | 3626 |
|
|
2021
Q3 | $825K | Sell |
82,500
-274
| -0.3% | -$2.74K | ﹤0.01% | 1278 |
|
|
2021
Q2 | $1.17M | Sell |
82,774
-198
| -0.2% | -$2.81K | ﹤0.01% | 1124 |
|
|
2021
Q1 | $1.36M | Hold |
82,972
| – | – | ﹤0.01% | 1002 |
|
|
2020
Q4 | $1.72M | Buy |
+82,972
| New | +$1.72M | ﹤0.01% | 870 |
|
|
2017
Q4 | – | Sell |
-700
| Closed | -$4K | – | 3657 |
|
|
2017
Q3 | $4K | Hold |
700
| – | – | ﹤0.01% | 3306 |
|
|
2017
Q2 | $6K | Hold |
700
| – | – | ﹤0.01% | 3171 |
|
|
2017
Q1 | $6K | Hold |
700
| – | – | ﹤0.01% | 3164 |
|
|
2016
Q4 | $6K | Sell |
700
-250
| -26% | -$2.14K | ﹤0.01% | 3153 |
|
|
2016
Q3 | $7K | Buy |
950
+250
| +36% | +$1.84K | ﹤0.01% | 3085 |
|
|
2016
Q2 | $3K | Hold |
700
| – | – | ﹤0.01% | 3314 |
|
|
2016
Q1 | $7K | Hold |
700
| – | – | ﹤0.01% | 3083 |
|
|
2015
Q4 | $7K | Buy |
+700
| New | +$7K | ﹤0.01% | 3144 |
|